WESLEY COOK: Open Payments
NPI 1376177154 · GREENEVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$748 in 57 payments from 14 companies in 2025. Trend: 2023 $625 · 2024 $785 · 2025 $748
Food & beverage: $748
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $220 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $135 |
| Ardelyx, Inc. | 3 | $61 |
| Novo Nordisk Inc | 3 | $58 |
| Xeris Pharmaceuticals, Inc. | 3 | $46 |
| Amgen Inc. | 3 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Exact Sciences Corporation | 2 | $31 |
| Phathom Pharmaceuticals, Inc. | 1 | $23 |
Products named: CAPLYTA, UBRELVY, VRAYLAR, IBSRELA, GVOKE HYPOPEN, OTEZLA, QULIPTA, Rybelsus.
Industry payments across TN — which companies pay providers there.
